Orexigen Therapeutics, Inc.OREX received a total of $22 million in milestone payments for its obesity drug, Contrave (EU trade name Mysimba), from its partners, Takeda Pharmaceutical Company Limited TKPYY and Kwang Dong Pharmaceutical Company Ltd. $15M Milestone Payment from